Two Sigma Advisers’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-401,265
| Closed | -$7.8M | – | 2592 |
|
|
2018
Q1 | $7.8M | Sell |
401,265
-58,200
| -13% | -$1.14M | 0.02% | 681 |
|
|
2017
Q4 | $7.65M | Sell |
459,465
-142,900
| -24% | -$2.62M | 0.02% | 698 |
|
|
2017
Q3 | $12.2M | Sell |
602,365
-353,362
| -37% | -$6.76M | 0.03% | 507 |
|
|
2017
Q2 | $15.4M | Sell |
955,727
-139,102
| -13% | -$2.05M | 0.05% | 400 |
|
|
2017
Q1 | $13.8M | Buy |
1,094,829
+43,511
| +4% | +$526K | 0.05% | 470 |
|
|
2016
Q4 | $13.9M | Buy |
1,051,318
+814,369
| +344% | +$13.9M | 0.05% | 380 |
|
|
2016
Q3 | $5.62M | Buy |
236,949
+48,900
| +26% | +$1.31M | 0.02% | 606 |
|
|
2016
Q2 | $5.42M | Buy |
188,049
+12,400
| +7% | +$404K | 0.03% | 528 |
|
|
2016
Q1 | $5.62M | Buy |
175,649
+14,071
| +9% | +$495K | 0.03% | 474 |
|
|
2015
Q4 | $6.91M | Buy |
161,578
+151,629
| +1,524% | +$6.06M | 0.04% | 386 |
|
|
2015
Q3 | $362K | Sell |
9,949
-42,500
| -81% | -$1.91M | ﹤0.01% | 1413 |
|
|
2015
Q2 | $2.41M | Buy |
52,449
+8,200
| +19% | +$389K | 0.02% | 724 |
|
|
2015
Q1 | $2.07M | Sell |
44,249
-14,200
| -24% | -$565K | 0.02% | 751 |
|
|
2014
Q4 | $1.85M | Sell |
58,449
-102,400
| -64% | -$3M | 0.01% | 868 |
|
|
2014
Q3 | $3.81M | Sell |
160,849
-32,900
| -17% | -$843K | 0.03% | 585 |
|
|
2014
Q2 | $5.81M | Sell |
193,749
-80,600
| -29% | -$2.17M | 0.05% | 433 |
|
|
2014
Q1 | $7.25M | Buy |
274,349
+3,300
| +1% | +$82.5K | 0.07% | 323 |
|
|
2013
Q4 | $6.82M | Buy |
271,049
+147,300
| +119% | +$3.29M | 0.07% | 307 |
|
|
2013
Q3 | $2.54M | Buy |
+123,749
| New | +$2.56M | 0.03% | 535 |
|
Two Sigma Advisers's IPXL Position: Q2 2018 in Review
Two Sigma Advisers sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 401,265 shares — an estimated $7.8M sold.
Two Sigma Advisers first reported a position in IPXL in Q3 2013 and held it in 19 quarters. The position peaked at $15.4M in Q2 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Two Sigma Advisers reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Two Sigma Advisers sold 401,265 Impax Laboratories, Inc. shares in Q2 2018, an estimated $7.8M.
- Two Sigma Advisers first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 19 quarters.
- Two Sigma Advisers's Impax Laboratories, Inc. position peaked at $15.4M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Two Sigma Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.